NCT04429412 is a NA clinical trial of MCT+ in Brief Psychotic Disorder, sponsored by Fundació Sant Joan de Déu.

Who is sponsoring NCT04429412?

NCT04429412 is sponsored by Fundació Sant Joan de Déu.

What drugs are being tested in NCT04429412?

Interventions in NCT04429412: MCT+.

What condition does NCT04429412 study?

NCT04429412 studies Brief Psychotic Disorder, Psychosis; Episode.

Is NCT04429412 still recruiting?

NCT04429412 is currently completed. Last updated 12 June 2020.

Last reviewed 2020-06-12 · How we verify

NCT04429412

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Completed NA Last updated 12 June 2020

What this trial tests

NA trial testing MCT+ in Brief Psychotic Disorder in 70 participants. Completed in 1 September 2018.

Timeline

1 January 2015

Primary endpoint
1 September 2016

1 September 2018

Quick facts

Lead sponsor	Fundació Sant Joan de Déu
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	70
Start date	1 January 2015
Primary completion	1 September 2016
Estimated completion	1 September 2018

Drugs / interventions tested

MCT+

Conditions studied

Brief Psychotic Disorder — all drugs for Brief Psychotic Disorder →
Psychosis; Episode — all drugs for Psychosis; Episode →

Sponsor

Fundació Sant Joan de Déu — full company profile →

Who can join

Adults 18 to 45, any sex, with Brief Psychotic Disorder or Psychosis; Episode. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Males and females with first episode psychosis present distinct profiles of social cognition and metacognition.
Ferrer-Quintero M, Fernández D, López-Carrilero R, Birulés I, et al · · 2022 · cited 13× · PMID 35802165 · DOI 10.1007/s00406-022-01438-0
Persons with first episode psychosis have distinct profiles of social cognition and metacognition.
Ferrer-Quintero M, Fernández D, López-Carrilero R, Birulés I, et al · · 2021 · cited 10× · PMID 34887442 · DOI 10.1038/s41537-021-00187-8
Influence of Maternal and Paternal History of Mental Health in Clinical, Social Cognition and Metacognitive Variables in People with First-Episode Psychosis.
Mendoza-García S, García-Mieres H, Lopez-Carrilero R, Sevilla-Lewellyn-Jones J, et al · · 2022 · cited 3× · PMID 36294871 · DOI 10.3390/jpm12101732

Verify or expand the search:

Other recruiting trials for Brief Psychotic Disorder

Currently open trials in the same condition.

NCT06423651 — Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders · NA · recruiting

Other Fundació Sant Joan de Déu trials

Trials by the same sponsor.

NCT07508917 — Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation · Phase 1, PHASE2 · not yet recruiting
NCT06556251 — Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme · NA · recruiting
NCT06309121 — Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents · NA · active not recruiting
NCT07091344 — Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis · NA · recruiting
NCT06340555 — Intervention to Prevent Mental Health Disorders of Women and Their Partners Who Experienced Pregnancy Loss · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04429412 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundació Sant Joan de Déu
Last refreshed: 12 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04429412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing